News
The Latest Industry News
The History of Metformin
Posted on September 18, 2017Metformin is one of the most commonly used medications in endocrinology. It is the preferred first-line oral blood glucose-lowering medicine to manage type 2 diabetes. It is also used in the treatment of polycystic ovary syndrome. Sometimes it is used, along with other medications, to treat infertility. The journal Diabetologia dedicated a special issue this […]
Read More
New Medication Option for Osteoporosis Treatment
Posted on July 17, 2017The Food and Drug Administration (FDA) has approved Tymlos (abaloparatide) injection for the treatment of postmenopausal women with osteoporosis at high risk for fracture. High risk for fracture is defined as history of osteoporotic fracture, multiple risk factors for fracture, or patients who have failed or are intolerant to other available osteoporosis therapy. In postmenopausal women with […]
Read More
New technology is “game changer” for patients with Type 1 diabetes
Posted on June 9, 2017See the segment on Fox 7 News featuring Texas Diabetes & Endocrinology founder Thomas Blevins, MD for more information on this exciting new technology! http://www.fox7austin.com/good-day/257839964-story
Read More
One of world’s most prestigious endocrinology conferences comes to Austin!
Posted on May 19, 2017Texas Diabetes & Endocrinology was excited about one the world’s largest endocrinology conferences being in Austin this year. The Annual Scientific & Clinical Congress of the American Association of Clinical Endocrinologists was held in Downtown Austin between May 3rd and 7th. This is a world-renowned meeting which highlights the latest technological and medical advances in […]
Read More
Texas Diabetes & Endocrinology is awarded AlUM Ultrasound Practice Accreditation
Posted on March 17, 2017The Ultrasound Practice Accreditation Council of the American Institute of Ultrasound in Medicine is pleased to announce that Texas Diabetes & Endocrinology has been awarded practice accreditation in the area of thyroid ultrasound. Texas Diabetes & Endocrinology achieved this recognition by meeting rigorous voluntary guidelines set by the diagnostic ultrasound profession. All facets of the […]
Read More
Dr. Luis Casaubon Achieves American Board of Internal Medicine Recertification
Posted on February 10, 2017Congratulations to Dr. Casaubon at our Central Austin office for completing all the required stages, and achieving recertification in Diabetes, Endocrinology and Metabolism. All our endocrinologists are board certified by the American Board of Internal Medicine. In order to maintain board certification, a specialist needs to take a comprehensive exam every ten years, and fulfill […]
Read More
Groundbreaking Ceremony at New Round Rock Office
Posted on January 27, 2017Construction at our new Texas Diabetes & Endocrinology office in Round Rock has started. The new building will allow us to serve our patients better by integrating our weight loss program, our research department, and will expand our clinic space. Our patients will also appreciate the increased parking space. The new building will be at […]
Read More
Continuous Glucose Monitors (CGMs) – Gold Standard of Care for Adults with Type 1 Diabetes
Posted on November 18, 2016The Endocrine Society recently issued a Clinical Practice Guideline recommending continuous glucose monitors (CGMs) as the gold standard of care for adults with Type 1 diabetes. Here at Texas Diabetes & Endocrinology, we provide comprehensive training and support for continuous glucose monitoring. The guideline, titled “Diabetes Technology—Continuous Subcutaneous Insulin Infusion Therapy and Continuous Glucose Monitoring […]
Read More
Texas Diabetes & Endocrinology Partners with MyDiabetesHome
Posted on November 11, 2016Texas Diabetes & Endocrinology is proud to announce our new partnership with MyDiabetesHome. MyDiabetesHome.com is a personalized diabetes management platform providing diabetic patients with tools to track blood sugar and manage medications. The interactive dashboard is easily accessible via computer, tablet or mobile device and allows patients to simplify their life, drastically improve doctor visits, […]
Read More
FDA approves first automated insulin-delivery device for type 1 diabetes
Posted on October 7, 2016The FDA announced the approval of Medtronic’s MiniMed 670G, the first hybrid closed loop system – often referred to as an “artificial pancreas” – on September 28th. The device is designed to check sugar levels, and provide appropriate insulin doses, based on those readings. It is currently approved for use for people aged 14 years and […]
Read More